Cargando…

Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET

Purpose. To assess whether the differences in vascular-metabolic relationships between lymphoma masses and colorectal liver metastases predicted from previous histopathological studies can be demonstrated by dynamic contrast-enhanced CT (DCE-CT) combined with fluorodeoxyglucose positron emission tom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miles, K. A., Williams, R. E., Yu, D., Griffiths, M. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094879/ https://www.ncbi.nlm.nih.gov/pubmed/21629862 http://dx.doi.org/10.1155/2011/679473

Ejemplares similares

Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours
por: Jesinghaus, Moritz, et al.
Publicado: (2022)

Intertumoural Heterogeneity and Branch Evolution of Synchronous Multiple Primary Lung Adenocarcinomas by Next-Generation Sequencing Analysis
por: Zhang, Qinleng, et al.
Publicado: (2021)

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer
por: Woolf, D K, et al.
Publicado: (2014)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity
por: Pesenti, Chiara, et al.
Publicado: (2019)

Measurement of SUVs-Maximum for Normal Region Using VOI in PET/MRI and PET/CT
por: Park, Jeong Kyu, et al.
Publicado: (2014)

FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma
por: Roberge, David, et al.
Publicado: (2012)

Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
por: Catalano, O A, et al.
Publicado: (2015)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
por: Cheah, C Y, et al.
Publicado: (2013)

Comparison of Contrast-Enhanced Ultrasound and Positron Emission Tomography/Computed Tomography (PET/CT) in Lymphoma
por: Niu, Xiaoyan, et al.
Publicado: (2018)

Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
por: Arrangoiz, Rodrigo, et al.
Publicado: (2012)

Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role
por: Del Giudice, Ginevra, et al.
Publicado: (2015)

PET/CT Is Complementary to Fine-Needle Aspiration Cytology in Assessment of Irradiated Neck in Head and Neck Cancers
por: Chan, R. C. L., et al.
Publicado: (2014)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016)

Hepatocellular Adenoma: Evaluation with Contrast-Enhanced Ultrasound and MRI and Correlation with Pathologic and Phenotypic Classification in 26 Lesions
por: Manichon, Anne-Frédérique, et al.
Publicado: (2012)

Using PET/CT Bone Scan Dynamic Data to Evaluate Tibia Remodeling When a Taylor Spatial Frame Is Used: Short and Longer Term Differences
por: Lundblad, Henrik, et al.
Publicado: (2015)

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
por: De Bruyne, S, et al.
Publicado: (2012)

A First Report on [(18)F]FPRGD(2) PET/CT Imaging in Multiple Myeloma
por: Withofs, Nadia, et al.
Publicado: (2017)

Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies
por: Pannu, Harpreet K., et al.
Publicado: (2013)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Dynamic 18FDG PET/CT and dynamic contrast enhanced MRI of locally advanced breast cancer
por: Kupik, O, et al.
Publicado: (2014)

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas
por: Benz, Matthias R., et al.
Publicado: (2010)

Comparison of Dynamic Contrast-Enhanced MRI and PET/CT in the Evaluation of Laryngeal Cancer After Inadequate CT Results
por: Citil, Serdal, et al.
Publicado: (2015)

Dynamic contrast enhanced CT in nodule characterization: How we review and report
por: Qureshi, Nagmi R., et al.
Publicado: (2016)

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging
por: Morgan, B, et al.
Publicado: (2006)

Investigation of Dose Minimisation Protocol for (18)F-FDG PET-CT in the Management of Lymphoma Postchemotherapy Followup
por: Sonoda, L. I., et al.
Publicado: (2012)

What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?
por: Bhosale, Priya, et al.
Publicado: (2013)

Automatic Segmentation of Lung Carcinoma Using 3D Texture Features in 18-FDG PET/CT
por: Markel, Daniel, et al.
Publicado: (2013)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: Net enhancement and standardized uptake values are related to tumour size and histology
por: Brunese, Luca, et al.
Publicado: (2013)

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
por: Koleva-Kolarova, R G, et al.
Publicado: (2015)

Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey
por: Annunziata, Salvatore, et al.
Publicado: (2023)

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy
por: Uchida, Kenzo, et al.
Publicado: (2013)

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings
por: Cao, Jiaying, et al.
Publicado: (2018)

Metabolic Volumetric Parameters in (11)C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
por: Tseng, Jing-Ren, et al.
Publicado: (2018)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

Correlation of Dynamic PET and Gene Array Data in Patients with Gastrointestinal Stromal Tumors
por: Strauss, Ludwig G., et al.
Publicado: (2012)

Concurrent FDG Avid Nasopharyngeal Lesion and Generalized Lymphadenopathy on PET-CT Imaging Is Indicative of Lymphoma in Patients with HIV Infection
por: Liu, Yiyan
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ucsfksaol1ud37c1qlo4tjl3g